BioPharmaStock
HomeAsk About StockNewsIdeasHistoryFDA DesignationsElite Program

NVNO

No price yet

Announcements

Nothing here yet

Daily updates

Nothing here yet

FDA designations

Nothing here yet

News

  • enVVeno Medical highlighted a newly issued U.S. patent strengthening its competitive position ahead of its pivotal trialJul 15, 2026
  • enVVeno Medical secured a key U.S. patent for the enVVe System ahead of its pivotal FDA trialJul 8, 2026
  • enVVeno Medical received the first-ever FDA IDE approval for a U.S. pivotal study of a non-surgical replacement venous valveApr 29, 2026
  • enVVeno received unfavorable appeal decision from the FDA for the VenoValveNov 14, 2025
  • enVVeno Medical updates regulatory status of VenoValve®Sep 15, 2025

    Bio Pharma Stock

    Where Science Meets Investing.

    BioPharmaStock is a specialized biopharmaceutical investment intelligence company focused exclusively on publicly traded biotechnology and pharmaceutical companies. Our research team continuously analyzes clinical trials, FDA regulatory events, scientific publications, corporate developments, and market catalysts to deliver timely research and exclusive insights for investors seeking opportunities in one of the world's most knowledge-intensive sectors.

    ALNJAM ALAALI SOFTWARE DESIGN CO. L.L.C, UAE, Abu Dhabi

    BioPharmaStock LogoBioPharmaStock Logo

    Quick Links

    • Home
    • Ask About Stock
    • News
    • Ideas
    • History
    • FDA Designations
    • Elite Program

    Contact Us

    Email: info@biopharmastock.com

    Phone: +971 50 936 3328

    Join Our Community→

    Follow Us

    Get the App

    Instant notifications on your phone

    Download on theApp StoreGet it onGoogle Play

    © 2026 Bio Pharma Stock. All rights reserved. Policy